跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ridocof - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ridocof
Approved
STANDARD
Ridocof
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a473ce19f17f83e6
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
a473ce19f17f83e6
Drug Approval Philippines Name
Ridocof
Product Name
Ridocof
Registration Number
DRP-395
Brand Name
Ridocof
Generic Name
Paracetamol + Phenylephrine hydrochloride + Dextromethorphan hydrobromide
Dosage Form
Capsule
Dosage Strength
325 mg/25 mg/10 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Eurohealth Care Exponents, Inc.
Distributor
Pryce Pharmaceuticals Inc.
Issuance Date
25 May 2025
Expiry Date
08 June 2031
Pharmacologic Category
Analgesic-Antipyretic/ Nasal Decongestant/Antitussive
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a473ce19f17f83e6
Type
Standard
Back to Philippines FDA Approvals